{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:15:52Z","timestamp":1793103352968,"version":"4.5.0"},"reference-count":40,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UNESP-Reitoria","award":["#2812-2021"],"award-info":[{"award-number":["#2812-2021"]}]},{"name":"UNESP-Reitoria","award":["#2021\/00372-1"],"award-info":[{"award-number":["#2021\/00372-1"]}]},{"name":"UNESP-Reitoria","award":["5552\/2024 PROPG\/PROPE No. 06\/2024"],"award-info":[{"award-number":["5552\/2024 PROPG\/PROPE No. 06\/2024"]}]},{"name":"UNESP-Reitoria","award":["001"],"award-info":[{"award-number":["001"]}]},{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"crossref","award":["#2812-2021"],"award-info":[{"award-number":["#2812-2021"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"crossref","award":["#2021\/00372-1"],"award-info":[{"award-number":["#2021\/00372-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"crossref","award":["5552\/2024 PROPG\/PROPE No. 06\/2024"],"award-info":[{"award-number":["5552\/2024 PROPG\/PROPE No. 06\/2024"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"crossref","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009568","name":"UNESP","doi-asserted-by":"crossref","award":["#2812-2021"],"award-info":[{"award-number":["#2812-2021"]}],"id":[{"id":"10.13039\/501100009568","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009568","name":"UNESP","doi-asserted-by":"crossref","award":["#2021\/00372-1"],"award-info":[{"award-number":["#2021\/00372-1"]}],"id":[{"id":"10.13039\/501100009568","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009568","name":"UNESP","doi-asserted-by":"crossref","award":["5552\/2024 PROPG\/PROPE No. 06\/2024"],"award-info":[{"award-number":["5552\/2024 PROPG\/PROPE No. 06\/2024"]}],"id":[{"id":"10.13039\/501100009568","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009568","name":"UNESP","doi-asserted-by":"crossref","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100009568","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior - Brasil","doi-asserted-by":"crossref","award":["#2812-2021"],"award-info":[{"award-number":["#2812-2021"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior - Brasil","doi-asserted-by":"crossref","award":["#2021\/00372-1"],"award-info":[{"award-number":["#2021\/00372-1"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior - Brasil","doi-asserted-by":"crossref","award":["5552\/2024 PROPG\/PROPE No. 06\/2024"],"award-info":[{"award-number":["5552\/2024 PROPG\/PROPE No. 06\/2024"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior - Brasil","doi-asserted-by":"crossref","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"abstract":"<jats:p>Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is characterized by chronic inflammation, which may be associated with hepatic and biliary manifestations such as non-alcoholic fatty liver disease (NAFLD). Despite the high risk of hepatic manifestations among patients with IBD, few studies in Brazil have assessed the frequency of these diseases. Therefore, this study aimed to analyze the prevalence of liver disease by ultrasound in patients with IBD. This was a single-center, cross-sectional study that included patients with IBD who were followed up at an outpatient clinic. The clinical and sociodemographic data, disease activity, biochemical test results, and Doppler liver ultrasonography results were assessed. Descriptive and association tests were used for statistical analyses. A total of 138 patients were included: 64.49% females, mean age 45.55\u00b114.17 years, and body mass index of 26.92\u00b15.07 kg\/m2. In total, 63 (45.65%) patients had CD and 75 (54.35%) had UC. Most patients were in either clinical (58.39%) or endoscopic remission (52.55%). Liver ultrasound revealed NAFLD in 58 patients (42.03%), which was classified as mild (36.21%), moderate (46.55%), or severe (17.24%). Seven patients had choledocholithiasis and three had chronic liver disease. Liver disease was associated with changes in aspartate aminotransferase (AST), alanine aminotransferase (ALT), hematocrit, hemoglobin, and fasting glucose levels. Liver disease is frequent in IBD patients, with NAFLD being the most prevalent. Screening for liver disease in patients with IBD is recommended for early detection and immediate treatment of the alterations, in order to prevent complications and progression to cirrhosis.<\/jats:p>","DOI":"10.1590\/1414-431x2025e14523","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:04:43Z","timestamp":1760713483000},"source":"Crossref","is-referenced-by-count":2,"title":["Investigation of liver diseases using liver Doppler ultrasound in patients with inflammatory bowel diseases"],"prefix":"10.1590","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0695-4473","authenticated-orcid":false,"given":"D.N.","family":"Shintaku","sequence":"first","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5241-2486","authenticated-orcid":false,"given":"M.A.","family":"Lopes","sequence":"additional","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8398-5014","authenticated-orcid":false,"given":"R.F.","family":"Beraldo","sequence":"additional","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil; Funda\u00e7\u00e3o Dracenense de Educa\u00e7\u00e3o e Cultura,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5357-3468","authenticated-orcid":false,"given":"E.C.S. de","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8159-4618","authenticated-orcid":false,"given":"G.S.P.","family":"Herrerias","sequence":"additional","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1303-1500","authenticated-orcid":false,"given":"A.C.B. de","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4035-3113","authenticated-orcid":false,"given":"J.P.","family":"Baima","sequence":"additional","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3915-6443","authenticated-orcid":false,"given":"W.F.","family":"Barbosa","sequence":"additional","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6129-7045","authenticated-orcid":false,"given":"G.F.","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7319-8906","authenticated-orcid":false,"given":"L.Y.","family":"Sassaki","sequence":"additional","affiliation":[{"name":"Universidade Estadual Paulista,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser C","year":"2019","journal-title":"J Crohns Colitis"},{"issue":"4","key":"ref2","first-page":"206","article-title":"The gut microbiome","volume":"46","author":"Sidhu M","year":"2017","journal-title":"Aust Fam Physician"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14740\/gr990w","article-title":"Hepatobiliary Manifestations and complications in inflammatory bowel disease: a review","volume":"11","author":"Fousekis FS","year":"2018","journal-title":"Gastroenterology Res"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1572-0241.2006.00947.x","article-title":"Abnormal hepatic biochemistries in patients with inflammatory bowel disease","volume":"102","author":"Mendes FD","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.4254\/wjh.v13.i12.1956","article-title":"Liver manifestations and complications in inflammatory bowel disease: a review","volume":"13","author":"Gaspar R","year":"2021","journal-title":"World J Hepatol"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management","volume":"161","author":"Rogler G","year":"2021","journal-title":"Gastroenterology"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/apt.16879","article-title":"Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease","volume":"55","author":"Zamani M","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjad108","article-title":"ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease","volume":"18","author":"Gordon H","year":"2024","journal-title":"J Crohns Colitis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"7604939","DOI":"10.1155\/2019\/7604939","article-title":"Frequency of hepatobiliary manifestations and concomitant liver disease in inflammatory bowel disease patients","volume":"2019","author":"Silva J","year":"2019","journal-title":"Biomed Res Int"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi J","year":"2006","journal-title":"Gut"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.MIB.0000215091.77492.2a","article-title":"Predicting the Crohn's disease activity index from the Harvey-Bradshaw Index","volume":"12","author":"Best WR","year":"2006","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl A","key":"ref12","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg MS","year":"2005","journal-title":"Can J Gastroenterol"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ibd.20520","article-title":"Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis","volume":"14","author":"Lewis JD","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"ref14","first-page":"1961","article-title":"Nonalcoholic fatty liver disease","volume":"73","author":"Bayard M","year":"2006","journal-title":"Am Fam Physician"},{"issue":"6512","key":"ref15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.292.6512.13","article-title":"Ultrasound scanning in the detection of hepatic fibrosis and steatosis","volume":"292","author":"Saverymuttu SH","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/MIB.0000000000000832","article-title":"Incidence and predictors of nonalcoholic fatty liver disease by serum biomarkers in patients with inflammatory bowel disease","volume":"22","author":"Bessissow T","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"42","key":"ref17","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.3748\/wjg.v19.i42.7327","article-title":"Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver","volume":"19","author":"Rojas-Feria M","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"37","key":"ref18","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.3748\/wjg.v25.i37.5676","article-title":"Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: beyond the natural history","volume":"25","author":"Magr\u00ec S","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/MEG.0000000000001679","article-title":"Non-alcoholic fatty liver disease in inflammatory bowel disease patients","volume":"32","author":"Karaivazoglou K","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"34","key":"ref20","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.3748\/wjg.v22.i34.7727","article-title":"Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: a review article","volume":"22","author":"Chao CY","year":"2016","journal-title":"World J Gastroenterol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/gastroent14010002","article-title":"Hepatobiliary Impairments in Patients with Inflammatory Bowel Diseases: The Current Approach","volume":"14","author":"Ionescu VA","year":"2023","journal-title":"Gastroenterol Insights"},{"key":"ref22","first-page":"235","article-title":"Prevalence of liver steatosis in abdominal ultrasound","volume":"22","author":"Parise ER","year":"2003","journal-title":"Gastrenterol Endosc Digest"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1665-2681(19)31584-4","article-title":"Nonalcoholic fatty liver disease in Brazil. Clinical and histological profile","volume":"10","author":"Cotrim HP","year":"2011","journal-title":"Ann Hepatol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"22","author":"Manne V","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/ibd\/izy051","article-title":"Nonalcoholic fatty liver disease in inflammatory bowel disease: prevalence and risk factors","volume":"24","author":"Principi M","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"NAFLD Nomenclature consensus group. A multi-society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella ME","year":"2023","journal-title":"J Hepatol"},{"issue":"19","key":"ref27","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.3390\/jcm12196216","article-title":"Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: the patient and physician perspective","volume":"12","author":"Eskridge W","year":"2023","journal-title":"J Clin Med"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome- a new world-wide definition. A consensus statement from the International Diabetes Federation","volume":"23","author":"Alberti KG","year":"2006","journal-title":"Diabetes Med"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"e20231321","DOI":"10.1590\/1806-9282.20231321","article-title":"Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center","volume":"70","author":"Oliveira LDRP","year":"2024","journal-title":"Rev Assoc Med Bras (1992)"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.cgh.2022.01.039","article-title":"Increased risk of MAFLD and liver fibrosis in inflammatory bowel disease independent of classic metabolic risk factors","volume":"21","author":"Rodriguez-Duque JC","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref31","series-title":"StatPearls [Internet]","volume-title":"Cholelithiasis. 2023","author":"Tanaja J","year":"2024"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"e0185193","DOI":"10.1371\/journal.pone.0185193","article-title":"Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases","volume":"12","author":"Fagagnini S","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.21537","article-title":"Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study","volume":"45","author":"Parente F","year":"2007","journal-title":"Hepatology"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1046\/j.1365-2036.2003.01529.x","article-title":"Bile composition in inflammatory bowel disease: ileal disease and colectomy, but not colitis, induce lithogenic bile","volume":"17","author":"Pereira SP","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12794","article-title":"Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease","volume":"40","author":"Gizard E","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.29328\/journal.acgh.1001025","article-title":"Systematic review and meta-analysis of drug induced liver injury secondary to biologic medications in inflammatory bowel disease","volume":"5","author":"Gadour E","year":"2021","journal-title":"Ann Clin Gastroenterol Hepatol"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/FTD.0000000000001031","article-title":"Predictive algorithm for thiopurine-induced hepatotoxicity in inflammatory bowel disease patients","volume":"44","author":"van Moorsel SAW","year":"2022","journal-title":"Ther Drug Monit"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review","volume":"10","author":"White DL","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"46","key":"ref39","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.3748\/wjg.v26.i46.7367","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis","volume":"26","author":"Hoffmann P","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3390\/medicina59111935","article-title":"Ultrasound prevalence and clinical features of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: a real-life cross-sectional study","volume":"59","author":"Abenavoli L","year":"2023","journal-title":"Medicina (Kaunas)"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0100-879X2025000100674&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:04:55Z","timestamp":1760713495000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2025000100674&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":40,"alternative-id":["S0100-879X2025000100674"],"URL":"https:\/\/doi.org\/10.1590\/1414-431x2025e14523","relation":{},"ISSN":["1414-431X","0100-879X"],"issn-type":[{"value":"1414-431X","type":"electronic"},{"value":"0100-879X","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e14523"}}